biospecimen__admin__batch_number	203.73.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	653A583B-B9C7-4FE3-9543-41374062B17B
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A1EG-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A1EG-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A1EG-01A
biospecimen__bio__biospecimen_barcode_bottom	0122969263
biospecimen__bio__day_of_creation	14
biospecimen__bio__day_of_shipment	24
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	03
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-DD-A1EG.D3F371AB-487A-47A8-8EE7-2D27D62FE482.pdf
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A213
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	1.95
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A1EG
biospecimen__shared__patient_id	A1EG
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A1EG-A43855
clinical__ablation__bcr_ablation_uuid	3171B121-F52B-4493-B41C-B53451B22CD5
clinical__ablation__days_to_embolization_performed	1070
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Other
clinical__ablation__embolization_therapy_drug_name_other	chemoembolic mixture
clinical__ablation__embolization_type	Chemoembolization
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	AFE90470-5F58-4D7D-84FC-C525B5BF1253
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.2
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	16
clinical__chol_lihc_shared__fibrosis_ishak_score	1,2 - Portal Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12.0
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	9.1
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	76
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A1EG-F42003
clinical__clin_shared__bcr_followup_uuid	643FFA7A-4953-46BF-9B9B-DEB26E2ABBB7
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	9
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	146
clinical__clin_shared__post_op_ablation_embolization_tx	YES
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2007
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	1006
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-DD-A1EG-D43858
clinical__rx__bcr_drug_uuid	55D863E7-C0D9-44E5-8BCE-EE5A1587A652
clinical__rx__days_to_drug_therapy_end	1310
clinical__rx__days_to_drug_therapy_start	1154
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	caf05305-45bc-4858-b8b5-21fe37061a5c
gdc__aliquots__concentration	0.15
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A1EG-01A-11R-A213-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	d4a4fea3-c835-4a79-8c54-1ce2766e115a,2cc27703-9b79-414c-bb7c-87f89655f770,2c503dd9-0e6f-434e-a086-433346d82b3e
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.76
gdc__analytes__analyte_id	5b12991f-e4df-4ec6-9187-cfde1b75ccd4
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	6c79f64b-63fe-46f5-bf7b-77208231b0f2
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-30T18:16:54.509616-05:00,2016-05-30T18:16:54.834087-05:00,2016-05-30T18:16:54.675470-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	9bec5f4c-ae0f-578b-a4a4-6f546c27d502
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1931
gdc__demographic__year_of_death	2010
gdc__diagnoses__age_at_diagnosis	28108
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-28108.0
gdc__diagnoses__days_to_death	1372.0
gdc__diagnoses__diagnosis_id	158560c6-156d-5bd8-8f68-b849f97902f4
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	29.05328798185941
gdc__exposures__exposure_id	d817eb19-fb48-5d3c-b57b-112f053b5410
gdc__exposures__height	168.0
gdc__exposures__weight	82.0
gdc__file_id	90ee4da4-5d50-4182-abea-14327e9557f8,cee7912a-70a7-4a3c-9dda-d2efc73ec36d,6faf56fc-16a2-4f30-afb0-3915b905cd97
gdc__file_name	beecd1d5-6b7e-42fc-a623-b4bdb179f87d.htseq.counts.gz,beecd1d5-6b7e-42fc-a623-b4bdb179f87d.FPKM.txt.gz,beecd1d5-6b7e-42fc-a623-b4bdb179f87d.FPKM-UQ.txt.gz
gdc__file_size	248200,496141,497545
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	5b97f8e0e9877ca61b96f5fd1a2eb7c6,d30edc61a272ec2246faf8903db056fc,4523c7cf48ac63211cf2407099ac7c14
gdc__portions__is_ffpe	false
gdc__portions__portion_id	67decfba-d757-44f6-9605-5d050d6c3c26
gdc__portions__portion_number	11
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1386
gdc__samples__initial_weight	20.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	D3F371AB-487A-47A8-8EE7-2D27D62FE482
gdc__samples__sample_id	e8b59658-06c6-46b7-b51f-ed52de0c403e
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	5.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	0bc94007-69d3-4ed1-8e6c-9d88c27ed705
gdc__submitter_id	beecd1d5-6b7e-42fc-a623-b4bdb179f87d_count,beecd1d5-6b7e-42fc-a623-b4bdb179f87d_fpkm,beecd1d5-6b7e-42fc-a623-b4bdb179f87d_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	96b8deb2-528f-548e-802b-35bfa7ee06fc
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:10:44.098+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/caf05305-45bc-4858-b8b5-21fe37061a5c-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/caf05305-45bc-4858-b8b5-21fe37061a5c-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5069513
manually_curated__local_md5	351bf087e9796a31769b369bdbe5e9c9
manually_curated__opengdc_download_date	2018-10-15T16:27:14.000072+02:00
manually_curated__opengdc_file_md5	40aa721692347d1335ec7f92e6c0307a
manually_curated__opengdc_file_size	1627920
manually_curated__opengdc_id	caf05305-45bc-4858-b8b5-21fe37061a5c-geq
manually_curated__origin_file_size	5069513
manually_curated__origin_last_modified_date	Mon Oct 15 16:41:00 CEST 2018
manually_curated__origin_md5	351bf087e9796a31769b369bdbe5e9c9
manually_curated__tissue_status	tumoral
num	60483
